What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Entero Healthcare Solutions Limited IPO?

Entero Healthcare Solutions Limited IPO has received a total subscription of 1.56 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Entero Healthcare Solutions Limited

ListedMainboard

Industrial & Financial Services · NSE / BSE

Entero Healthcare Solutions Limited was founded in 2018 and is a leading distributor of healthcare products in India. Using a technology-driven platform, the company supplies healthcare products to pharmacies, hospitals, and clinics across the country. Key Highlights: Growing Customer Base: Served 39,500+ retail customers in 2021, 64,200+ in 2022, and 81,400+ in 2023. Also served 1,600+ hospitals in 2021, 2,500+ in 2022, and 3,400+ in 2023. Strong Manufacturer Network: Partnered with 1,900+ healthcare product manufacturers, offering access to 64,500+ product SKUs (as of March 31, 2023). Extensive Infrastructure: Operates 73 warehouses in 37 cities across 19 states and union territories, covering 495 districts in India. Large Workforce: As of March 31, 2023, the company has 3,014 employees across various departments. With its vast distribution network and strong industry relationships, Entero Healthcare Solutions continues to expand its reach in the healthcare sector.

Price Band

₹1195 – ₹1258

Issue Size

₹1600 Cr

Lot Size

11 shares

GMP

₹2

+0.2%

Est. Listing

₹1260

at current GMP

Subscribed

1.56x

overall

Open

9 Feb 2024

13 Feb 2024

Allotment

14 Feb 2024

Refund

15 Feb 2024

Demat Credit

16 Feb 2024

Listing

16 Feb 2024

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

1.56x

Total Demand

QIB Multiplier

2.29x

Institutions & Funds

NII / HNI

0.22x

High Net-Worth

Retail (RII)

1.38x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 1.56x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	3,796,503	8,686,172	2.29x
NIB	1,898,251	426,756	0.22x
HNIs(10L +)	1,265,500	213,895	0.17x
HNIs (2-10L)	632,751	212,861	0.34x
RETAIL	1,265,500	1,743,885	1.38x
EMPLOYEES	70,237	93,071	1.33x
Total	8,928,742	11,376,640	1.56x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1.34x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	404,683	558,463	1.38x
HNIs (10L +)	2,589	570	0.22x
HNIs (2-10L)	12,388	2,725	0.22x
Total Applications	419,660	561,758	1.34x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Entero Healthcare Solutions Limited Public Issue & Market Profile

Entero Healthcare Solutions Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹1,600 Crores. The shares are offered at a price band of ₹1195 to ₹1258 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2024-02-13, the basis of allotment is scheduled to be finalized on 2024-02-14. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Entero Healthcare Solutions Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Entero Healthcare Solutions Limited IPO is ₹2 per equity share. Based on the upper price band of ₹1195 to ₹1258 per equity share, the estimated listing price is ₹1260 (+0.2% expected listing gain).

What is the expected profit per lot for Entero Healthcare Solutions Limited IPO?

With a lot size of 11 shares and current GMP of ₹2, the expected profit per application lot is approx ₹22 (+0.2% gain). Minimum application cost is approx ₹13,838.

What is the issue size and price band for Entero Healthcare Solutions Limited IPO?

The Entero Healthcare Solutions Limited IPO aggregate issue size is ₹1,600 Crores with an equity price band set at ₹1195 to ₹1258 per equity share. The retail lot size is 11 shares requiring a minimum capital outlay of approx. ₹13,838.

How can I check Entero Healthcare Solutions Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 1.56x (Retail: 1.38x, QIB: 2.29x, NII: 0.22x). You can track live multiples directly on our dedicated subscription page.

Where and when will Entero Healthcare Solutions Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2024-02-14. Investors can verify status using PAN card or application number.

When is the listing date for Entero Healthcare Solutions Limited IPO?

Entero Healthcare Solutions Limited shares are scheduled to list on NSE and BSE on 2024-02-16.